共 50 条
- [1] Risk Factors for Pericardial and Pleural Effusions in Heart Transplant Recipients Exposed to Everolimus, Azathioprine, or MMF [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S86 - S87
- [2] Dynamics of Pleural Effusions in the Presence of Everolimus-Based Immunosuppression in De Novo Cardiac Transplant Recipients [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S202 - S202
- [4] Wound Healing Events and Effusions with Everolimus Versus MMF Based Regimens in De Novo Heart Transplant Recipients [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S87 - S87
- [7] EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS [J]. VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (02): : 74 - 81
- [8] Comparability of Pattern of Occurrence of Pericardial Effusions between Everolimus- and MMF-Based Regimen in De Novo Cardiac Transplant Recipients [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S170 - S170
- [9] Early vs. Delayed EVERolimus in De Novo HEART Transplant Recipients [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S35 - S35